Optomed Oyj reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 15.1 million compared to EUR 14.66 million a year ago. Net loss was EUR 4.44 million compared to EUR 5.47 million a year ago.

Basic loss per share from continuing operations was EUR 0.27 compared to EUR 0.37 a year ago.